Tiger Brokers

  • Markets
    • Quotes
    • 24/7 News
  • Products
    • Cash Boost Account
    • Options
    • China A-shares
    • HK Stocks
    • Fixed Coupon Notes
    • US Stocks
    • ETFs
    • Funds
    • US Treasury
    • Singapore Stocks
    • Futures
    • Tiger BOSS Debit Card
    • Tiger Vault
  • Features
    • Auto-invest
    • Invest with CPF/SRS
    • Learn
    • US Fractional Shares
  • TigerAI
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Statement
      • Statement
      • Dividends
  • Institution
    • Tiger Fund Management
    • Institution Service
      • Wealth and asset manager
      • Proprietary trading institutions
      • Introducing brokers
      • Third-party service provider
    • Tiger Open Platform
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Avenue Therapeutics, Inc.

0.6518
-0.0231-3.42%
Volume:1.41K
Turnover:953.20
Market Cap:2.08M
PE:-0.49
High:0.7630
Open:0.6513
Low:0.6513
Close:0.6749
52wk High:2.23
52wk Low:0.1653
Shares:3.18M
Float Shares:2.83M
Volume Ratio:1.60
T/O Rate:0.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3329
EPS(LYR):-8.9962
ROE:-191.15%
ROA:-77.30%
PB:0.58
PE(LYR):-0.07

Loading ...

OverviewCompanyNewsFilings

Avenue Therapeutics Inc. Announces Date for Upcoming Annual Stockholder Meeting

Reuters
·
Dec 06

Axsome Therapeutics Acquires Baergic Bio and Global Rights to BAER-101 from Avenue Therapeutics

Reuters
·
Nov 12

Axsome Therapeutics Acquires Global Rights to AZD7325 for Epilepsy Treatment

Reuters
·
Nov 06

Axsome Therapeutics Acquires Subtype Selective Gaba-a Receptor Positive Allosteric Modulator Azd7325 for the Treatment of Epilepsy

THOMSON REUTERS
·
Nov 06

Axsome Therapeutics Inc - to Begin Phase 2 Trial Activities for Azd7325 in 2026

THOMSON REUTERS
·
Nov 06

Axsome Therapeutics Inc - Obtains Exclusive Global Rights to Azd7325

THOMSON REUTERS
·
Nov 06

Avenue Therapeutics Inc - Baergic Bio Shareholders to Receive $0.3 Mln Upfront

THOMSON REUTERS
·
Nov 06

Avenue Therapeutics Q2 EPS $0.11 Up From $(6.43) YoY, Sales $1.404M

Benzinga
·
Aug 15

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Nov 14, 2024 Post Market
Financial Report Announcement
Aug 09, 2024 Post Market
Financial Report Announcement
May 15, 2024 Pre-Market
Split&Reverse Split
Apr 26, 2024 75 for 1
Financial Report Announcement
Mar 18, 2024 Post Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-0.17
Current
-4.33
Sector Average
99.59%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-0.17
Maximum
-0.16
+1 STD
0.60
Minimum
-22.30
-1 STD
-9.26
Average
-4.33

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.